Multibagger 2023

#1
Synthiko Foils, a company with 28 years of experience in manufacturing aluminum foils for pharmaceutical packaging, has been consistently profitable. With two successful manufacturing units in Thane and Maharashtra, the company operates without any debt obligations. Currently, there are 17 lakh shares, with 52.72% held by promoters and 47.28% by the general public, resulting in a limited number of shares in circulation.

The company has reported eight consecutive profitable quarters, with only one negative result. The recent positive quarterly results indicate a promising future. The stock is likely to experience a continuous upward rally towards 1000, making it an attractive investment opportunity. Synthiko Foils focuses on pharma-related products, further boosting its growth prospects.

Compared to MRF, a highly priced stock in India, Synthiko Foils has fewer shares, many of which are held by long-term investors. This indicates significant upside potential for the company. As demand increases, particularly on the BSE where it is listed, the share price is expected to rise. Based on my study, as the company's market capitalization expands, its business and profits are likely to grow, positioning it for further success.

In line with Warren Buffett's investment strategies, the current range of 200 rupees to 500 rupees presents a favorable opportunity to invest in the company. Synthiko Foils has a target of reaching 1000 within the next 5 months, with only a limited number of shares available for selling (below 7000).
Key Financial Highlights:
  • Quarterly Net Profit in March 2023: Rs. 0.09 crore (up 425% from March 2022's Rs. 0.02 crore).
  • EBITDA in March 2023: Rs. 0.30 crore (up 66.67% from March 2022's Rs. 0.18 crore).
  • EPS in March 2023: Rs. 0.51 (up from March 2022's Rs. 0.10).
  • Synthiko Foils' shares closed at 180.60 on May 31, 2023 (BSE), with -34.17% returns over the last 6 months and 342.11% returns over the last 12 months.
 

mohan.sic

Well-Known Member
#2
Synthiko Foils, a company with 28 years of experience in manufacturing aluminum foils for pharmaceutical packaging, has been consistently profitable. With two successful manufacturing units in Thane and Maharashtra, the company operates without any debt obligations. Currently, there are 17 lakh shares, with 52.72% held by promoters and 47.28% by the general public, resulting in a limited number of shares in circulation.

The company has reported eight consecutive profitable quarters, with only one negative result. The recent positive quarterly results indicate a promising future. The stock is likely to experience a continuous upward rally towards 1000, making it an attractive investment opportunity. Synthiko Foils focuses on pharma-related products, further boosting its growth prospects.

Compared to MRF, a highly priced stock in India, Synthiko Foils has fewer shares, many of which are held by long-term investors. This indicates significant upside potential for the company. As demand increases, particularly on the BSE where it is listed, the share price is expected to rise. Based on my study, as the company's market capitalization expands, its business and profits are likely to grow, positioning it for further success.

In line with Warren Buffett's investment strategies, the current range of 200 rupees to 500 rupees presents a favorable opportunity to invest in the company. Synthiko Foils has a target of reaching 1000 within the next 5 months, with only a limited number of shares available for selling (below 7000).
Key Financial Highlights:
  • Quarterly Net Profit in March 2023: Rs. 0.09 crore (up 425% from March 2022's Rs. 0.02 crore).
  • EBITDA in March 2023: Rs. 0.30 crore (up 66.67% from March 2022's Rs. 0.18 crore).
  • EPS in March 2023: Rs. 0.51 (up from March 2022's Rs. 0.10).
  • Synthiko Foils' shares closed at 180.60 on May 31, 2023 (BSE), with -34.17% returns over the last 6 months and 342.11% returns over the last 12 months.

nonsense post....
 
#4
Synthiko Foils, a company with 28 years of experience in manufacturing aluminum foils for pharmaceutical packaging, has been consistently profitable. With two successful manufacturing units in Thane and Maharashtra, the company operates without any debt obligations. Currently, there are 17 lakh shares, with 52.72% held by promoters and 47.28% by the general public, resulting in a limited number of shares in circulation.

The company has reported eight consecutive profitable quarters, with only one negative result. The recent positive quarterly results indicate a promising future. The stock is likely to experience a continuous upward rally towards 1000, making it an attractive investment opportunity. Synthiko Foils focuses on pharma-related products, further boosting its growth prospects.

Compared to MRF, a highly priced stock in India, Synthiko Foils has fewer shares, many of which are held by long-term investors. This indicates significant upside potential for the company. As demand increases, particularly on the BSE where it is listed, the share price is expected to rise. Based on my study, as the company's market capitalization expands, its business and profits are likely to grow, positioning it for further success.

In line with Warren Buffett's investment strategies, the current range of 200 rupees to 500 rupees presents a favorable opportunity to invest in the company. Synthiko Foils has a target of reaching 1000 within the next 5 months, with only a limited number of shares available for selling (below 7000).
Key Financial Highlights:
  • Quarterly Net Profit in March 2023: Rs. 0.09 crore (up 425% from March 2022's Rs. 0.02 crore).
  • EBITDA in March 2023: Rs. 0.30 crore (up 66.67% from March 2022's Rs. 0.18 crore).
  • EPS in March 2023: Rs. 0.51 (up from March 2022's Rs. 0.10).
  • Synthiko Foils' shares closed at 180.60 on May 31, 2023 (BSE), with -34.17% returns over the last 6 months and 342.11% returns over the last 12 months.
Go away.........
 

Similar threads